Quick recap
This informal group discussion focused on kratom advocacy, regulatory updates, and personal experiences within the kratom community. Christopher shared news that a Kratom bill was pulled in Iowa and discussed ongoing efforts in Tennessee and Kentucky, while the group also discussed FDA developments, including a recently released dose-finding study on kratom safety.
The conversation covered concerns about poor-quality products on the market containing unknown ingredients such as 7OH and pseudo-oxylone, with participants emphasizing the importance of transparency and proper labeling. The discussion also touched on personal health topics, including Twinkle's weight-loss journey and Madalyn's use of supplements such as ashwagandha and reishi, before concluding with a casual conversation about the weather and food preferences.
Summary
Kratom Legislation Updates Discussion
The group discussed updates on kratom legislation, with Christopher sharing news that Senator Zimmer in Iowa had pulled the Kratom bill from the debate calendar, though he noted mixed sentiment in Iowa, with some supporting regulations over a ban. The conversation also touched on ongoing efforts in Tennessee and Kentucky regarding kratom legislation, with Christopher expressing hope that federal recognition of kratom's safety could help reduce state-level restrictions, particularly for kratom tea.
Kratom Product Purity Challenges
Christopher and Twinkle discussed the challenges of ensuring product purity and transparency in the regulated industry, particularly in the context of kratom products. They highlighted issues such as unlisted ingredients, potential contamination, and the presence of harmful substances like pseudoindoxyl and fentanyl. Christopher emphasized the importance of disclosure and clarity in product information, sharing past experiences with fraudulent lab results and customer complaints about unexpected contaminants. Both agreed on the need for independent testing to build trust and ensure consumer safety.
Kratom Industry Transparency Concerns
Christopher expressed concerns about the lack of transparency in the kratom industry, particularly regarding unclear labeling and potentially dangerous products. He highlighted specific issues with the 70H product, including unknown fragments and inconsistent dosing, emphasizing the need for accurate and honest labeling. Christopher also discussed broader industry improvements in transparency over the past decade and expressed optimism about recent government efforts to promote health and transparency, particularly mentioning RFK's involvement.
Traditional Medicine Integration Discussion
Christopher and Twinkle discussed the challenges of finding reliable information and the impact of misinformation, particularly since COVID-19. They explored the benefits of returning to traditional practices, including herbal medicine, plant-based diets, and grounding techniques like walking barefoot. Christopher highlighted the importance of simple, functional activities for health and suggested that modern medicine should integrate more traditional knowledge, while Venus mentioned the potential value in preserving Native American plant medicine practices.
Personal Care and Kratom Regulation
Christopher and Twinkle discussed the importance of taking care of personal needs, with Christopher comparing it to drinking water. They then talked about house chores and maintaining a clean living space. Christopher shared a video of a government official discussing the regulation of dietary supplements and the need to address bad actors in the industry, particularly regarding kratom products. He emphasized the distinction between the kratom leaf and other kratom products to avoid giving the supplement a bad reputation.
Kratom FDA Regulations Update
Christopher discussed the current state of FDA regulations regarding kratom, noting that while specific dosage limits are still being determined, the Leaf has been deemed safe for consumption up to certain limits as of 2026. He expressed optimism about the current administration's approach to addressing pain patient undertreatment and mentioned upcoming meetings with RFK Jr.'s team regarding chronic pain patients. Christopher also reflected on the challenges faced by industry leaders working to establish safe practices and guidelines, while acknowledging improvements in FDA leadership under the current administration.
Fast-Tracking Pain and Rare Drugs
The group discussed the fast-tracking of pain medications and rare disease drugs, with Christopher expressing hope for better treatment options for pain patients while learning from past opioid distribution mistakes. Twinkle shared her personal experience with reducing nicotine use through vaping, explaining her gradual approach to minimize stress and avoid relapse. The conversation concluded with Twinkle updating the group about her husband's medical situation, including stable heart function at 27-40% ejection fraction, and their plans to potentially move from their current location to either Southern California or Arizona.
Student Placement and Success Concerns
Twinkle expressed concerns about a school district's plan to place her young sons in a class with no chance of graduation, arguing they should have the opportunity to succeed rather than be failed. She shared a personal story about her adult son, who had a head injury at age 14, which led to him being homeschooled rather than returning to traditional school. Christopher shared his own experience of struggling to catch up after a head injury in third grade, which resulted in repeating fifth grade and facing significant academic challenges. Both participants agreed that it was premature to label these young students as failures before giving them proper opportunities to succeed.
Community and Connection Discussion
Twinkle and Christopher discussed the importance of community and connection, particularly within the group they are part of. Twinkle shared how being part of this group has provided support and a sense of community, especially during challenging times. They also talked about their efforts to limit phone use during group activities and how they manage different phones for work and personal use.
Device Usage and Personal Updates
The group discussed their phone and laptop usage, with Twinkle explaining how she uses older Samsung phones for different purposes while keeping them charged. Christopher shared that he still uses his first laptop from when he started his business in 2016 and discussed the importance of receiving security updates to maintain device safety. The conversation then shifted to weather conditions and ended with Twinkle sharing her weight-loss progress, noting she had lost weight and improved her mobility.
Kratom Treatment for Dogs
Christopher discussed his experience with Kratom for his 14-year-old dog, who takes about 2 grams daily in the form of capsules and tincture. He shared details about the dog's treatment regimen, which includes Kratom in the morning and Benadryl at night, and expressed concerns about a case in Tennessee where Kratom was incorrectly blamed for a death involving high levels of Benadryl. Christopher noted that the FDA is conducting safety studies on Kratom, including on plain leaf and specific extracts like MGM-15 and 7-0H, and emphasized that the current administration is more receptive to understanding the benefits of Kratom compared to previous efforts to suppress information.
Kratom and Herbal Regulation Challenges
Christopher and Madalyn discussed the challenges with FDA regulations regarding kratom and herbal medicine, expressing frustration with resistance from some FDA officials. They shared personal experiences with supplements, including ashwagandha, reishi mushrooms, and L-theanine, discussing their effects and how they incorporate these into their routines. Christopher also mentioned issues with social media platforms restricting his content, particularly on Instagram and Facebook, highlighting the challenges faced by advocates in sharing information about kratom and herbal remedies.
Kratom Regulations and Health Discussion
The group discussed various topics, including Wawa convenience stores and their expansion, weather conditions in different regions, and Mitrospec's potential relocation. They also talked about the ongoing challenges with Kratom regulations, particularly in Tennessee and other states, expressing concerns about the impact on those who rely on it for pain management. The conversation touched on personal experiences with opioids and the medical system, highlighting the stigma faced by patients in chronic pain. The conversation ended with plans for upcoming events, including a potential appearance by Dan and Sarah from Mitraspec on Saturday's show.https://vimeo.com/1182013434?share=copy&fl=sv&fe=ci